
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Neil Friedman, COO of Bodimetrics, explains how pharmacists can best leverage the Bodimetrics Performance Monitor technology in their day-to-day practice.
Neil Friedman, COO of Bodimetrics, explains how pharmacists can best leverage the Bodimetrics Performance Monitor technology in their day-to-day practice.
This video was recorded at the NACDS Total Store Expo in August 2015 in Denver, Colorado.






